Log in to save to my catalogue

SARS-CoV-2 seroprevalence and infection rate in Manila, Philippines prior to national vaccination pr...

SARS-CoV-2 seroprevalence and infection rate in Manila, Philippines prior to national vaccination pr...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f5ea2d669d0b4d048ac34933c8c0d9f3

SARS-CoV-2 seroprevalence and infection rate in Manila, Philippines prior to national vaccination program implementation: a repeated cross-sectional analysis

About this item

Full title

SARS-CoV-2 seroprevalence and infection rate in Manila, Philippines prior to national vaccination program implementation: a repeated cross-sectional analysis

Publisher

Japan: Springer

Journal title

Tropical Medicine and Health, 2022-10, Vol.50 (1), p.75-13, Article 75

Language

English

Formats

Publication information

Publisher

Japan: Springer

More information

Scope and Contents

Contents

SARS-CoV-2 seroepidemiological studies are used to guide public health decision making and to prepare for emerging infectious diseases. Disease occurrence estimates are limited in the Philippines, the country with the highest reported number of coronavirus disease-related deaths in the Western Pacific region. We aimed to estimate SARS-CoV-2 seropre...

Alternative Titles

Full title

SARS-CoV-2 seroprevalence and infection rate in Manila, Philippines prior to national vaccination program implementation: a repeated cross-sectional analysis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_f5ea2d669d0b4d048ac34933c8c0d9f3

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f5ea2d669d0b4d048ac34933c8c0d9f3

Other Identifiers

ISSN

1349-4147,1348-8945

E-ISSN

1349-4147

DOI

10.1186/s41182-022-00468-7

How to access this item